Annual CFI
$44.66 M
+$280.07 M+118.97%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual cash flow from investing activities is $44.66 million, with the most recent change of +$280.07 million (+118.97%) on December 31, 2023.
- During the last 3 years, ALXO annual CFI has risen by +$44.05 million (+7220.82%).
- ALXO annual CFI is now at all-time high.
Performance
ALXO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$25.69 M
+$24.79 M+2732.75%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly cash flow from investing activities is $25.69 million, with the most recent change of +$24.79 million (+2732.75%) on September 30, 2024.
- Over the past year, ALXO quarterly CFI has increased by +$12.88 million (+100.49%).
- ALXO quarterly CFI is now -39.25% below its all-time high of $42.30 million, reached on March 31, 2023.
Performance
ALXO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$36.41 M
+$12.88 M+54.73%
September 30, 2024
Summary
- As of February 7, 2025, ALXO TTM cash flow from investing activities is $36.41 million, with the most recent change of +$12.88 million (+54.73%) on September 30, 2024.
- Over the past year, ALXO TTM CFI has dropped by -$35.86 million (-49.62%).
- ALXO TTM CFI is now -50.23% below its all-time high of $73.14 million, reached on June 30, 2023.
Performance
ALXO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ALXO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +119.0% | +100.5% | -49.6% |
| 3 y3 years | +7220.8% | +114.0% | +119.3% |
| 5 y5 years | +6938.7% | +10000.0% | +5839.1% |
ALXO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.0% | -39.3% | +114.0% | -50.2% | +113.7% |
| 5 y | 5-year | at high | +119.0% | -39.3% | +114.0% | -50.2% | +113.7% |
| alltime | all time | at high | +119.0% | -39.3% | +114.0% | -50.2% | +113.7% |
ALX Oncology Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $25.69 M(+2732.7%) | $36.41 M(+54.7%) |
| Jun 2024 | - | $907.00 K(-96.6%) | $23.53 M(-18.4%) |
| Mar 2024 | - | $26.47 M(-258.8%) | $28.84 M(-35.4%) |
| Dec 2023 | $44.66 M(-119.0%) | -$16.67 M(-230.1%) | $44.66 M(-38.2%) |
| Sep 2023 | - | $12.81 M(+106.3%) | $72.27 M(-1.2%) |
| Jun 2023 | - | $6.21 M(-85.3%) | $73.14 M(-895.1%) |
| Mar 2023 | - | $42.30 M(+286.5%) | -$9.20 M(-96.1%) |
| Dec 2022 | -$235.42 M(+4682.0%) | $10.94 M(-20.1%) | -$235.42 M(-6.2%) |
| Sep 2022 | - | $13.70 M(-118.0%) | -$250.88 M(-5.3%) |
| Jun 2022 | - | -$76.13 M(-58.6%) | -$264.97 M(+40.3%) |
| Mar 2022 | - | -$183.92 M(+3970.8%) | -$188.84 M(+3735.8%) |
| Dec 2021 | -$4.92 M | -$4.52 M(+1035.2%) | -$4.92 M(+1083.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$398.00 K(<-9900.0%) | -$416.00 K(-167.9%) |
| Jun 2021 | - | $0.00(-100.0%) | $613.00 K(0.0%) |
| Mar 2021 | - | -$7000.00(-36.4%) | $613.00 K(+0.5%) |
| Dec 2020 | $610.00 K(-272.8%) | -$11.00 K(-101.7%) | $610.00 K(-10.7%) |
| Sep 2020 | - | $631.00 K(>+9900.0%) | $683.00 K(+1213.5%) |
| Jun 2020 | - | $0.00(-100.0%) | $52.00 K(-121.2%) |
| Mar 2020 | - | -$10.00 K(-116.1%) | -$245.00 K(-30.6%) |
| Dec 2019 | -$353.00 K(-45.9%) | $62.00 K(>+9900.0%) | -$353.00 K(-14.9%) |
| Sep 2019 | - | $0.00(-100.0%) | -$415.00 K(0.0%) |
| Jun 2019 | - | -$297.00 K(+151.7%) | -$415.00 K(+251.7%) |
| Mar 2019 | - | -$118.00 K | -$118.00 K |
| Dec 2018 | -$653.00 K | - | - |
FAQ
- What is ALX Oncology Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual CFI year-on-year change?
- What is ALX Oncology Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly CFI year-on-year change?
- What is ALX Oncology Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM CFI year-on-year change?
What is ALX Oncology Holdings annual cash flow from investing activities?
The current annual CFI of ALXO is $44.66 M
What is the all time high annual CFI for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual cash flow from investing activities is $44.66 M
What is ALX Oncology Holdings annual CFI year-on-year change?
Over the past year, ALXO annual cash flow from investing activities has changed by +$280.07 M (+118.97%)
What is ALX Oncology Holdings quarterly cash flow from investing activities?
The current quarterly CFI of ALXO is $25.69 M
What is the all time high quarterly CFI for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly cash flow from investing activities is $42.30 M
What is ALX Oncology Holdings quarterly CFI year-on-year change?
Over the past year, ALXO quarterly cash flow from investing activities has changed by +$12.88 M (+100.49%)
What is ALX Oncology Holdings TTM cash flow from investing activities?
The current TTM CFI of ALXO is $36.41 M
What is the all time high TTM CFI for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM cash flow from investing activities is $73.14 M
What is ALX Oncology Holdings TTM CFI year-on-year change?
Over the past year, ALXO TTM cash flow from investing activities has changed by -$35.86 M (-49.62%)